Geera Desai
Psychiatry · Greenville, SCNPI 1184684961
Payments from drug & device makers
Across 169 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$771
- Alkermes, Inc.$640
- Otsuka America Pharmaceutical, Inc.$509
- AbbVie$372
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$348
- Teva Pharmaceuticals USA, Inc.$283
- plus $989 from 11 others
What the payments were for
- Food & beverage$3,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 32 | $771 |
| Alkermes, Inc. | 17 | $640 |
| Otsuka America Pharmaceutical, Inc. | 28 | $509 |
| AbbVie(2 entities) | 19 | $372 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $348 |
| Teva Pharmaceuticals USA, Inc. | 19 | $283 |
| E.r. Squibb & Sons, L.L.C. | 9 | $244 |
| Neurocrine Biosciences, Inc. | 8 | $205 |
| Novo Nordisk | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 6 | $121 |
| Indivior Inc. | 5 | $101 |
| Lundbeck LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$959
- LYBALVI$407
- INVEGA SUSTENNA$350
- ARISTADA INITIO$240
- COBENFY$125
- Wegovy$122
- REXULTI$122
- INGREZZA$106
How this compares
$3,912 in reported general payments places this provider in the 85th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 136 | $416,041 |
| IngrezzaValbenazine Tosylate | 12 | $101,447 |
| Abilify MaintenaAripiprazole | 36 | $100,739 |
| Abilify AsimtufiiAripiprazole | 13 | $68,173 |
| RexultiBrexpiprazole | 32 | $51,520 |
| VraylarCariprazine Hcl | 24 | $41,800 |
| CaplytaLumateperone Tosylate | 11 | $18,615 |
| Aripiprazole | 113 | $15,363 |
| Lurasidone Hcl | 20 | $13,057 |
| TrintellixVortioxetine Hydrobromide | 11 | $6,967 |
| Quetiapine Fumarate | 118 | $4,796 |
| Divalproex Sodium ErDivalproex Sodium | 56 | $2,880 |
| Hydroxyzine Hcl | 106 | $2,864 |
| Olanzapine | 119 | $2,775 |
| Paliperidone ErPaliperidone | 14 | $2,292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $771 | $416,041136 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti | $509 | $220,43281 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $205 | $101,44712 claims |
| AbbVieVraylar | $372 | $41,80024 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $348 | $18,61511 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $22 | $6,96711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Greenville
- Jeffrey StephensGreenville$195K
- Robert RichardsGreenville$142K
- Lisa WischhusenGreenville$14K
- Jeffrey SmithGreenville$10K
- Lauren LevyGreenville$7K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
- Veronica RidpathFlorence$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.